Insilco and Invitro approaches identify novel dual PI3K/AKT pathway inhibitors to control acute myeloid leukemia cell proliferations
Mohammad Abohassan, Mesfer Alshahrani, Mohammad Y. Alshahrani, Prasanna Rajagopalan
Topics & Concepts
Protein kinase BPI3K/AKT/mTOR pathwayCancer researchMyeloid leukemiaDocking (animal)Cell growthChemistrySignal transductionCell biologyPharmacologyBiologyBiochemistryMedicineNursingAcute Myeloid Leukemia ResearchHistone Deacetylase Inhibitors ResearchProtein Degradation and Inhibitors